FDA Regulator Throws Shade on Therapy, Wall Street Whispers Panic
In a rare ancient ritual called 'Tweeting from the FDA,' a top drug regulator tossed major shade on an unnamed therapy, stirring Wall Street investors into a collective frenzy of eyebrow raises and frantic portfolio reconsiderations. No company names, no dollar values, just the pure, unfiltered power of social media snark causing tremors on exchange floors. Apparently, regulators have discovered Twitter, and the market's reaction was somewhere between 'OMG' and 'BRB selling everything.' Nothing says 'trust the science' like behind-the-scenes Twitter die-hard skepticism igniting trading floors faster than a Tesla on Ludicrous Mode.
Share the Story
Wall Street’s new diet plan: banish therapy with FDA tweets and watch investors panic like squirrels at a hawk convention. Stirring drama without names, cash amounts, or facts — just pure regulator roast demanding popcorn and portfolio defense strategies.
When your top FDA regulator publicly roasts a therapy on social media, you don't need market data — you get investor anxiety in real-time, which apparently is more volatile than crypto on a caffeine binge.
FDA’s viral diss of an unnamed therapy is the new politeness standard: why release official statements when a 280-character clapback can tank stocks with zero accountability?
Source: Statnews | Published: 9/29/2025 | Author: Adam Feuerstein
More Articles in Business
Sydney Sweeney's $1M Flop, Trump-Approved Jeans & Bathwater Soap Fiasco
Digital Nomad Trapped in Lisbon FOMO, Ends Up BFF Ghosted
Traveler Confirms Small Towns Are America’s Scenic Waiting Rooms
Workday CEO Wonders Who to Replace with AI Before Deciding to Lay Off 400 Humans
David Ellison’s 10th WBD Offer: Slightly Better Than Doing Nothing
AI Slaps White-Collar Jobs, Blue-Collars Brace for Gig Economy Chain Reaction
Costco, Toyota & FedEx Sue Trump For Tariff Refunds Like It’s Black Friday Cashback
Lamborghini Cancels Silent EV, Citing Absence of Vroom-Feelz
